Medicx Share Discussion Threads

[skinny] 13/3/2017 08:04

MedicX Fund Limited, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom and Ireland, is pleased to announce that it has contracted to acquire, by way of forward funding, a new primary healthcare medical centre in Cromer, Norfolk. The property is due to be completed in March 2018.

The acquisition is being made under a new three year framework agreement which provides MedicX Fund the exclusive right to acquire, by way of forward funding, new primary healthcare schemes from Medcentres plc ("Medcentres"), a leading developer of primary healthcare centres.

The completed development will consist 1,147 m2 let to the Cromer Group GP Practice and a local pharmacy under leases running for a term of 20 years from practical completion. The completed property is expected to cost £3.75 million.

The MedicX Fund's total property portfolio now comprises 154 properties throughout the United Kingdom and Republic of Ireland of which 147 are operational and fully let, with seven under construction. The annualised rent roll for all properties is now £37.8 million.


- End -

[speedsgh] 09/2/2017 16:07

Quarterly Net Asset Value ("NAV") announcement and business update -

NAV per share - 31/12/16: 72.4p (30/9/16: 71.7p) +1.0%
EPRA NAV per share - 31/12/16: 73.8p (30/9/16: 73.2p) +0.8%
EPRA NNNAV per share - 31/12/16: 62.3p (30/9/16: 56.4p) +10.5%

[redips2] 09/2/2017 15:04

Figs look OK..... happy holding .

[speedsgh] 26/1/2017 08:51

Joint Venture Agreement and Extension of GPIC Framework Agreement -

[ridicule] 06/1/2017 09:38

I have just bought 67,000 MXF and no buy shows on ADVFN? Not even on Level 2

[cheshire2] 01/11/2016 16:11

RNS Number : 9990N

The MedicX Fund Limited

01 November 2016

Press Release

For immediate release

1 November 2016

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Notice of dividend

The Directors have approved a quarterly dividend of 1.4875p per Ordinary Share in respect of the period 1 July 2016 to 30 September 2016. This will bring the total dividends declared in respect of the financial year ended 30 September 2016 to 5.95p per Ordinary Share, an increase of 0.85% over the dividends totalling 5.9p declared for the previous year ended 30 September 2015. The dividend will be paid on 31 December 2016 to ordinary shareholders on the register as at 18 November 2016 (the "Record Date"). The corresponding ex-dividend date will be 17 November 2016.

[skinny] 19/10/2016 15:13

MedicX Fund, (LSE: MXF), the specialist primary care infrastructure investor in modern, purpose-built, primary healthcare properties in the United Kingdom and Ireland, is pleased to announce that it has contracted to acquire, by way of forward funding, a new primary healthcare medical centre in Brynmawr, South Wales. The property is due to be completed in November 2017.
The acquisition is being made under the framework agreement with General Practice Investment Corporation ("GPI") which was agreed in May 2013.

The completed development will be let to the Local Health Board and Bestway Pharmacy. All leases will be for a term of 20 years from practical completion. The completed property will consist of 1,587 m2 with an initial passing rent of approximately £300,000 per annum, subject to three-yearly effectively upwards only market rent reviews.

The MedicX Fund's total property portfolio now comprises 153 properties throughout the United Kingdom and Republic of Ireland of which 146 are operational and fully let, with 7 under construction. The annualised rent roll for all properties is now £37.4 million.


- End -

[cheshire2] 04/10/2016 13:37

RNS Number : 6600L

The MedicX Fund Limited

04 October 2016

For immediate release

4 October 2016

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Issue of ordinary shares

MedicX Fund Limited announces that earlier today, Tuesday 4 October 2016, it issued for cash 2,000,000 ordinary shares of no par value in the Company. The ordinary shares were issued under the Company's block listing facility, at a price of 88.5 pence per share. This follows the issue of 1,000,000 ordinary shares earlier today at the same price.

The net proceeds will be used in further pursuing the investment objectives of the Company.

[badtime] 28/9/2016 15:42

Another million there Skinny ..just in the rns section

[skinny] 23/9/2016 13:24

MedicX Fund Limited announces that earlier today, Friday 23 September 2016, it issued for cash 1,000,000 ordinary shares of no par value in the Company. The ordinary shares were issued under the Company's block listing facility, at a price of 88.25 pence per share.

The net proceeds will be used in further pursuing the investment objectives of the Company.

Total voting rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares in the capital of the Company in issue following this transaction will be 386,897,760 (excluding treasury shares) each with one voting right.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules.

The Company also holds 8,354,422 ordinary shares in treasury and has 22,981,109 ordinary shares of no par value remaining under its block listing facility to be used to satisfy demand that cannot be met through the secondary market.


- End -

[skinny] 23/9/2016 13:24

MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom and Republic of Ireland, is pleased to announce that it has completed the amendment and restatement of its previous £25 million revolving credit facility.

On 15 September 2016, the facility term was extended for a new three year term ending in September 2019. In addition, the amendment also provides for an option, with lender consent, that the immediately committed £20 million revolving credit facility may be extended by a further £10 million to £30 million or additional lenders be added with a view to increasing the facility on existing terms.

Interest is payable on amounts drawn under the amended facility at a rate equal to LIBOR plus a lending margin of 2.00 per cent. per annum. A non-utilisation fee of between 1.10% and 0.75% will be payable on the reduced, £20 million immediately available commitment depending on the level of utilisation.

The Fund has £337 million of other debt facilities with a weighted average fixed cost of 4.45% including undrawn amounts, with an average remaining term of just over 14 years.



- End -

[skinny] 16/9/2016 15:14

MedicX Fund Limited (LSE: MXF), the specialist primary care infrastructure investor in modern purpose-built primary healthcare properties in the United Kingdom and Republic of Ireland, is pleased to announce that it has completed the amendment and restatement of its previous £25 million revolving credit facility.

On 15 September 2016, the facility term was extended for a new three year term ending in September 2019. In addition, the amendment also provides for an option, with lender consent, that the immediately committed £20 million revolving credit facility may be extended by a further £10 million to £30 million or additional lenders be added with a view to increasing the facility on existing terms.

Interest is payable on amounts drawn under the amended facility at a rate equal to LIBOR plus a lending margin of 2.00 per cent. per annum. A non-utilisation fee of between 1.10% and 0.75% will be payable on the reduced, £20 million immediately available commitment depending on the level of utilisation.

The Fund has £337 million of other debt facilities with a weighted average fixed cost of 4.45% including undrawn amounts, with an average remaining term of just over 14 years.



- End -

[badtime] 19/8/2016 12:16

Made up the fall already

[badtime] 16/8/2016 12:27

Ex div Thursday

[chester] 12/8/2016 16:08

Thanks speedsgh

[speedsgh] 11/8/2016 15:25

New Edison research note out...

More Irish expansion -

[skinny] 28/7/2016 13:15

A new high @91p.

[ridicule] 28/7/2016 12:06

This share is beginning to pop again. Great yield, but the current share price is well above current NAV. This has kept the share price pegged in the high 80s.

People are beginning to understand, however, that NAV will rise as the 15 or so medical centres in their construction phase come on line as rent generators.

This is a rock solid high yield investment with further capital gains to come as new medical centres are commissioned.

[rathkum] 26/7/2016 14:54

Perhaps income seekers looking for a yield. Seems to be heading to 90p

[badtime] 27/6/2016 15:10

81.5 earlier..just a few ..saving ammo for lower possibilities

[badtime] 27/6/2016 09:42

Bit lower and might add

[badtime] 16/6/2016 12:08

Drifting on rate fears through a possible no vote?

[speedsgh] 07/6/2016 13:11

Direct link available below to today's Edison note...

Continuing to find opportunities -